News
Dr. Reddys Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir
Dr. Reddy's Laboratories Ltd announced that it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. (Gilead)that will grant Dr. Reddy’s the...
News
Biocon and Mylan get U.S. FDA approval for insulin glargine injection
Mylan N.V. and Biocon Ltd. announced that the U.S. FDA has approved the New Drug Application (NDA) for Semglee (insulin glargine injection), in vial...
Press Releases
AstraZeneca to Supply Europe with 400M Doses of COVID-19 Vaccine
AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400...
Drug Research
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer...
News
Lonza Capsules and Health Ingredients introduces HPMC double-blinded capsules for clinical trials
A global capsule and equipment developer and manufacturer, Lonza has introduced an enhanced product line aimed at tackling concerns around bias during blinded clinical...
News
German Federal Government invests 300 Million Euros in CureVac
The German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp, SAP co-founder and co-founder of the investment company dievini Hopp...
Press Releases
Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test
llumina, Inc. is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. The U.S. FDA issued an EUA for the Illumina COVIDSeq™ Test,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read